Collegium Pharmaceutical, Inc.
COLL
$27.27
$0.220.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.68% | 882.63% | 995.02% | 417.77% | 292.60% |
| Total Depreciation and Amortization | 13.34% | -2.63% | -6.20% | -4.18% | 11.26% |
| Total Amortization of Deferred Charges | -30.33% | -27.61% | -20.50% | -15.85% | 4.22% |
| Total Other Non-Cash Items | -66.81% | -51.56% | -48.51% | -58.45% | 140.80% |
| Change in Net Operating Assets | -352.99% | -255.95% | -103.36% | 1,006.15% | 270.94% |
| Cash from Operations | -25.39% | -27.66% | 17.00% | 74.37% | 121.16% |
| Capital Expenditure | -258.35% | -0.73% | 16.96% | 49.53% | 71.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.61% | 28.86% | -31.74% | -- | -- |
| Cash from Investing | -306.37% | -545.36% | -30.29% | -5,152.31% | 87.66% |
| Total Debt Issued | 34.58% | 35.81% | -97.33% | -97.52% | -53.35% |
| Total Debt Repaid | -1.50% | -19.64% | 16.54% | 23.18% | -301.52% |
| Issuance of Common Stock | 21.67% | 11.13% | 13.75% | -24.06% | -25.08% |
| Repurchase of Common Stock | 5.00% | -20.22% | -482.56% | -294.01% | -360.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.30% | -- | -- | -- | -- |
| Cash from Financing | 56.77% | 11.23% | -874.87% | -1,960.74% | -132.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.88% | -258.31% | -169.49% | -126.03% | 600.54% |